Compare $EDIT vs $RCEL | Chartloom

Compare

$EDIT vs $RCEL

Editas Medicine Inc · AVITA Medical Inc

EDIT

Editas Medicine Inc

RCEL

AVITA Medical Inc

Compare $EDIT vs $RCEL

Comparing Editas Medicine Inc and AVITA Medical Inc

EDITEditas Medicine Inc

RCELAVITA Medical Inc

EDITEditas Medicine Inc

Market cap

$487M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

27.22x

Rev growth (TTM)

20.8%

YTD performance

41.5%

52W performance

-30.1%

FCF yield

-24.8%

RCELAVITA Medical Inc

Market cap

$407M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.05x

Rev growth (TTM)

1.0%

YTD performance

280.7%

52W performance

139.7%

FCF yield

-6.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

EDIT

RCEL

Detailed metrics comparison

EDIT

Editas Medicine Inc

RCEL

AVITA Medical Inc

Market Cap

EDIT$487M

RCEL$407M

Enterprise Value

EDIT$361M

RCEL$444M

Price

EDIT$2.90

RCEL$13.21

P/E Ratio

EDITN/A

RCELN/A

P/S Ratio

EDIT10.35x

RCEL5.38x

EV/Sales

EDIT7.67x

RCEL5.87x

EV/EBITDA

EDIT0.00x

RCEL0.00x

P/B Ratio

EDIT3.82x

RCEL87.44x

P/FCF Ratio

EDITN/A

RCELN/A

EV/FCF

EDIT-2.99x

RCEL-17.54x

PEG Ratio

EDITN/A

RCELN/A

Forward P/E (NTM)

EDITN/A

RCELN/A

Forward P/S (NTM)

EDIT27.22x

RCEL4.05x

Revenue (TTM)

EDIT$47M

RCEL$76M

Revenue Growth (YoY)

EDIT20.8%

RCEL1.0%

Forward Rev Growth

EDIT-18.4%

RCEL20.3%

Gross Margin (TTM)

EDIT0.0%

RCEL82.1%

Operating Margin (TTM)

EDIT0.0%

RCEL0.0%

EBITDA Margin (TTM)

EDIT-172.4%

RCEL-41.9%

Net Margin (TTM)

EDIT-157.3%

RCEL-57.0%

FCF Margin (TTM)

EDIT-256.5%

RCEL-33.5%

Net Income (TTM)

EDIT$-74M

RCEL$-43M

FCF (TTM)

EDIT$-121M

RCEL$-25M

EPS (TTM)

EDIT-$0.62

RCEL-$1.40

ROE (TTM)

EDIT-19663.0%

RCEL-33790.0%

ROA (TTM)

EDIT-3817.0%

RCEL-7853.0%

ROIC (TTM)

EDIT-7815.0%

RCEL-10295.0%

Cash

EDIT$182M

RCEL$9M

Debt

EDIT$56M

RCEL$47M

Net Cash/Debt

EDIT$126M

RCEL$-38M

Current Ratio (TTM)

EDIT3.19x

RCEL0.41x

Quick Ratio (TTM)

EDIT3.13x

RCEL0.31x

Debt/Equity (TTM)

EDIT0.53x

RCEL9.39x

Debt/Assets (TTM)

EDIT0.0%

RCEL0.0%

Interest Coverage (TTM)

EDITN/A

RCELN/A

Net Debt/EBITDA (TTM)

EDIT0.00x

RCEL0.00x

Beta

EDIT2.12

RCEL2.07

52W Performance

EDIT-30.1%

RCEL139.7%

YTD Performance

EDIT41.5%

RCEL280.7%

% from 52W High

EDIT-33.0%

RCEL-3.7%

% from 52W Low

EDIT74.7%

RCEL310.2%

Asset Turnover (TTM)

EDIT0.24x

RCEL1.38x

FCF Yield (TTM)

EDIT-24.8%

RCEL-6.2%

Earnings Yield (TTM)

EDIT-15.2%

RCEL-10.6%

Dividend Yield (TTM)

EDITN/A

RCELN/A

Rule of 40

EDIT-235.6

RCEL-32.5

EV/GP/RG

EDITN/A

RCEL0.22

Ticker research

View EDIT research View RCEL research

Metric	EDIT Editas Medicine Inc	RCEL AVITA Medical Inc
Market & Valuation
Market Cap	$487M	$407M
Enterprise Value	$361M	$444M
Price	$2.90	$13.21
P/E Ratio	N/A	N/A
P/S Ratio	10.35x	5.38x
EV/Sales	7.67x	5.87x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.82x	87.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.99x	-17.54x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	27.22x	4.05x
Revenue & Growth
Revenue (TTM)	$47M	$76M
Revenue Growth (YoY)	20.8%	1.0%
Forward Rev Growth	-18.4%	20.3%
Profitability
Gross Margin (TTM)	0.0%	82.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-172.4%	-41.9%
Net Margin (TTM)	-157.3%	-57.0%
FCF Margin (TTM)	-256.5%	-33.5%
Net Income (TTM)	$-74M	$-43M
FCF (TTM)	$-121M	$-25M
EPS (TTM)	-$0.62	-$1.40
ROE (TTM)	-19663.0%	-33790.0%
ROA (TTM)	-3817.0%	-7853.0%
ROIC (TTM)	-7815.0%	-10295.0%
Financial Health
Cash	$182M	$9M
Debt	$56M	$47M
Net Cash/Debt	$126M	$-38M
Current Ratio (TTM)	3.19x	0.41x
Quick Ratio (TTM)	3.13x	0.31x
Debt/Equity (TTM)	0.53x	9.39x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.12	2.07
52W Performance	-30.1%	139.7%
YTD Performance	41.5%	280.7%
% from 52W High	-33.0%	-3.7%
% from 52W Low	74.7%	310.2%
Efficiency & Yields
Asset Turnover (TTM)	0.24x	1.38x
FCF Yield (TTM)	-24.8%	-6.2%
Earnings Yield (TTM)	-15.2%	-10.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-235.6	-32.5
EV/GP/RG	N/A	0.22
Ticker research	View EDIT research	View RCEL research

Valuation

P/S Ratio

RCEL

5.38x

EDIT

10.35x

EV/FCF

RCEL

-17.54x

EDIT

-2.99x

Growth & revenue

Revenue Growth TTM

EDIT

20.8%

RCEL

1.0%

Forward Revenue Growth

RCEL

20.3%

EDIT

-18.4%

Profitability & performance

Gross Margin

RCEL

82.1%

EDIT

0.0%

ROE

EDIT

-19663.0%

RCEL

-33790.0%

FCF Yield %

RCEL

-6.2%

EDIT

-24.8%

52-Week Performance

RCEL

139.7%

EDIT

-30.1%

Detailed metrics comparison

EDIT

Editas Medicine Inc

RCEL

AVITA Medical Inc

Market Cap

EDIT$487M

RCEL$407M

Enterprise Value

EDIT$361M

RCEL$444M

Price

EDIT$2.90

RCEL$13.21

P/E Ratio

EDITN/A

RCELN/A

P/S Ratio

EDIT10.35x

RCEL5.38x

EV/Sales

EDIT7.67x

RCEL5.87x

EV/EBITDA

EDIT0.00x

RCEL0.00x

P/B Ratio

EDIT3.82x

RCEL87.44x

P/FCF Ratio

EDITN/A

RCELN/A

EV/FCF

EDIT-2.99x

RCEL-17.54x

PEG Ratio

EDITN/A

RCELN/A

Forward P/E (NTM)

EDITN/A

RCELN/A

Forward P/S (NTM)

EDIT27.22x

RCEL4.05x

Revenue (TTM)

EDIT$47M

RCEL$76M

Revenue Growth (YoY)

EDIT20.8%

RCEL1.0%

Forward Rev Growth

EDIT-18.4%

RCEL20.3%

Gross Margin (TTM)

EDIT0.0%

RCEL82.1%

Operating Margin (TTM)

EDIT0.0%

RCEL0.0%

EBITDA Margin (TTM)

EDIT-172.4%

RCEL-41.9%

Net Margin (TTM)

EDIT-157.3%

RCEL-57.0%

FCF Margin (TTM)

EDIT-256.5%

RCEL-33.5%

Net Income (TTM)

EDIT$-74M

RCEL$-43M

FCF (TTM)

EDIT$-121M

RCEL$-25M

EPS (TTM)

EDIT-$0.62

RCEL-$1.40

ROE (TTM)

EDIT-19663.0%

RCEL-33790.0%

ROA (TTM)

EDIT-3817.0%

RCEL-7853.0%

ROIC (TTM)

EDIT-7815.0%

RCEL-10295.0%

Cash

EDIT$182M

RCEL$9M

Debt

EDIT$56M

RCEL$47M

Net Cash/Debt

EDIT$126M

RCEL$-38M

Current Ratio (TTM)

EDIT3.19x

RCEL0.41x

Quick Ratio (TTM)

EDIT3.13x

RCEL0.31x

Debt/Equity (TTM)

EDIT0.53x

RCEL9.39x

Debt/Assets (TTM)

EDIT0.0%

RCEL0.0%

Interest Coverage (TTM)

EDITN/A

RCELN/A

Net Debt/EBITDA (TTM)

EDIT0.00x

RCEL0.00x

Beta

EDIT2.12

RCEL2.07

52W Performance

EDIT-30.1%

RCEL139.7%

YTD Performance

EDIT41.5%

RCEL280.7%

% from 52W High

EDIT-33.0%

RCEL-3.7%

% from 52W Low

EDIT74.7%

RCEL310.2%

Asset Turnover (TTM)

EDIT0.24x

RCEL1.38x

FCF Yield (TTM)

EDIT-24.8%

RCEL-6.2%

Earnings Yield (TTM)

EDIT-15.2%

RCEL-10.6%

Dividend Yield (TTM)

EDITN/A

RCELN/A

Rule of 40

EDIT-235.6

RCEL-32.5

EV/GP/RG

EDITN/A

RCEL0.22

Ticker research

View EDIT research View RCEL research

Metric	EDIT Editas Medicine Inc	RCEL AVITA Medical Inc
Market & Valuation
Market Cap	$487M	$407M
Enterprise Value	$361M	$444M
Price	$2.90	$13.21
P/E Ratio	N/A	N/A
P/S Ratio	10.35x	5.38x
EV/Sales	7.67x	5.87x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.82x	87.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.99x	-17.54x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	27.22x	4.05x
Revenue & Growth
Revenue (TTM)	$47M	$76M
Revenue Growth (YoY)	20.8%	1.0%
Forward Rev Growth	-18.4%	20.3%
Profitability
Gross Margin (TTM)	0.0%	82.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-172.4%	-41.9%
Net Margin (TTM)	-157.3%	-57.0%
FCF Margin (TTM)	-256.5%	-33.5%
Net Income (TTM)	$-74M	$-43M
FCF (TTM)	$-121M	$-25M
EPS (TTM)	-$0.62	-$1.40
ROE (TTM)	-19663.0%	-33790.0%
ROA (TTM)	-3817.0%	-7853.0%
ROIC (TTM)	-7815.0%	-10295.0%
Financial Health
Cash	$182M	$9M
Debt	$56M	$47M
Net Cash/Debt	$126M	$-38M
Current Ratio (TTM)	3.19x	0.41x
Quick Ratio (TTM)	3.13x	0.31x
Debt/Equity (TTM)	0.53x	9.39x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.12	2.07
52W Performance	-30.1%	139.7%
YTD Performance	41.5%	280.7%
% from 52W High	-33.0%	-3.7%
% from 52W Low	74.7%	310.2%
Efficiency & Yields
Asset Turnover (TTM)	0.24x	1.38x
FCF Yield (TTM)	-24.8%	-6.2%
Earnings Yield (TTM)	-15.2%	-10.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-235.6	-32.5
EV/GP/RG	N/A	0.22
Ticker research	View EDIT research	View RCEL research